Suberoylanilide hydroxamic acid suppresses hepatic stellate cells activation by HMGB1 dependent reduction of NF-κB1

PeerJ

Volumn 2015, Issue 11, 2015, Pages

  Wang, Wenwen ^a,b   Yan, Min ^a   Ji, Qiuhong ^a   Lu, Jinbiao ^a   Ji, Yuhua ^a   Ji, Juling ^a  

^a NANTONG UNIVERSITY   (China)

^b Department of Pathology   (China)

Author keywords

Hepatic stellate cell; High mobility group box 1; Histone deacetylase inhibitor; Liver fibrosis; Nuclear factor kappa B1; Suberoylanilide hydroxamic acid

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COMPLEMENTARY DNA; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B; SMALL INTERFERING RNA; VORINOSTAT;

ARTICLE; BIOINFORMATICS; CELL ACTIVATION; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENETIC TRANSFECTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; IC50; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LIVER FIBROSIS; LUCIFERASE ASSAY; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; WESTERN BLOTTING;

EID: 84948963858     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.1362     Document Type: Article

References (32)

1. Chen C, Zhang J, Li J, Huang J, Yang C, Huang G, Shi J. 2004. Hydrodynamic-based in vivo transfection of retinoic X receptor-alpha gene can enhance vitamin A-induced attenuation of liver fibrosis in mice. Liver International 24:679-686 DOI 10.1111/j.1478-3231.2004.0977.x.
2. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M,Walther TC, Olsen JV,Mann M. 2009. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325:834-840 DOI 10.1126/science.1175371.
3. Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM, Frankel SR. 2007. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 109:31-39 DOI 10.1182/blood-2006-06-025999.
4. Fabre C, Grosjean J, Tailler M, Boehrer S, Ades L, Perfettini JL, De Botton S, Fenaux P, Kroemer G. 2008. A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in malignant myeloblasts. Cell Cycle 7:2139-2145 DOI 10.4161/cc.7.14.6268.
5. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF. 2003. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101:2652-2660 DOI 10.1182/blood-2002-05-1300.
6. GeWS,Wu JX, Fan JG,Wang YJ, Chen YW. 2011. Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells. World Journal of Gastroenterology 17:4090-4098 DOI 10.3748/wjg.v17.i36.4090.
7. Ji J, Eggert T, Budhu A, Forgues M, Takai A, Dang H, Ye Q, Lee JS, Kim JH, Greten TF, Wang XW. 2015. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma. Hepatology 62:481-495 DOI 10.1002/hep.27822.
8. Li LC, Gao J, Li J. 2014. Emerging role of HMGB1 in fibrotic diseases. Journal of Cellular and Molecular Medicine 18:2331-2339 DOI 10.1111/jcmm.12419.
9. Li H, Zhang J, Huang G, Zhang N, Chen Q, Zhang X. 2002. Effect of retinoid kappa receptor alpha (RXRalpha) transfection on the proliferation and phenotype of rat hepatic stellate cells in vitro. Chinese Medical Journal 115:928-932.
10. Lopez-Rodas G, Brosch G, Georgieva EI, Sendra R, Franco L, Loidl P. 1993. Histone deacetylase. A key enzyme for the binding of regulatory proteins to chromatin. FEBS Letters 317:175-180 DOI 10.1016/0014-5793(93)81271-Z.
11. Lu B, Antoine DJ, Kwan K, Lundback P,Wahamaa H, Schierbeck H, Robinson M, Van Zoelen MA, Yang H, Li J, Erlandsson-Harris H, Chavan SS,Wang H, Andersson U, Tracey KJ. 2014. JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proceedings of the National Academy of Sciences of the United States of America 111:3068-3073 DOI 10.1073/pnas.1316925111.
12. Luan ZG, Zhang H, Yang PT,Ma XC, Zhang C, Guo RX. 2010. HMGB1 activates nuclear factor-kappaB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells. Immunobiology 215:956-962 DOI 10.1016/j.imbio.2009.11.001.
13. Mederacke I, Hsu CC, Troeger JS, Huebener P,Mu X, Dapito DH, Pradere JP, Schwabe RF. 2013. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nature Communications 4:2823 DOI 10.1038/ncomms3823.
14. Miyahara T, Schrum L, Rippe R, Xiong S, Yee Jr HF,Motomura K, Anania FA,Willson TM, Tsukamoto H. 2000. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. Journal of Biological Chemistry 275:35715-35722 DOI 10.1074/jbc.M006577200. Niki T, Rombouts K, De Bleser P, De Smet K, Rogiers V, Schuppan D, Yoshida M, Gabbiani G, Geerts A. 1999. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology 29:858-867 DOI 10.1002/hep.510290328.
15. Niki T, Rombouts K, De Bleser P, De Smet K, Rogiers V, Schuppan D, Yoshida M, Gabbiani G, Geerts A. 1999. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology 29:858-867 DOI 10.1002/hep.510290328
16. Park JS, Arcaroli J, Yum HK, Yang H,Wang H, Yang KY, Choe KH, Strassheim D, Pitts TM, Tracey KJ, Abraham E. 2003. Activation of gene expression in human neutrophils by high mobility group box 1 protein. American Journal Physiol Cell Physiology 284:C870-C879 DOI 10.1152/ajpcell.00322.2002.
17. Park KC, Park JH, Jeon JY, Kim SY, Kim JM, Lim CY, Lee TH, Kim HK, Lee HG, Kim SM, Kwon HJ, Suh JS, Kim SW, Choi SH. 2014. A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells. British Journal of Pharmacology 171:4820-4830 DOI 10.1111/bph.12590.
18. Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. 2014. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nature Reviews Immunology 14:181-194 DOI 10.1038/nri3623.
19. Puche JE, Saiman Y, Friedman SL. 2013. Hepatic stellate cells and liver fibrosis. Comprehensive Physiology 3:1473-1492 DOI 10.1002/cphy.c120035.
20. Rombouts K, Knittel T,Machesky L, Braet F,Wielant A, Hellemans K, De Bleser P, Gelman I, Ramadori G, Geerts A. 2002. Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. Journal of Hepatology 37:788-796 DOI 10.1016/S0168-8278(02)00275-1.
21. Sanderson L, Taylor GW, Aboagye EO, Alao JP, Latigo JR, Coombes RC, Vigushin DM. 2004. Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice. Drug Metabolism and Disposition: The Biological Fate of Chemicals 32:1132-1138 DOI 10.1124/dmd.104.000638.
22. Schuppan D, Kim YO. 2013. Evolving therapies for liver fibrosis. Journal of Clinical Investigation 123:1887-1901 DOI 10.1172/JCI66028.
23. Spange S,Wagner T, Heinzel T, Kramer OH. 2009. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. International Journal of Biochemistry and Cell Biology 41:185-198 DOI 10.1016/j.biocel.2008.08.027.
24. Teichgraber V, Ulrich M, Endlich N, Riethmuller J,Wilker B, De Oliveira-Munding CC, Van Heeckeren AM, Barr ML, Von Kurthy G, Schmid KW,Weller M, Tummler B, Lang F, Grassme H, Doring G, Gulbins E. 2008. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nature Medicine 14:382-391 DOI 10.1038/nm1748.
25. Travers AA. 2003. Priming the nucleosome: a role for HMGB proteins? EMBO Reports 4:131-136 DOI 10.1038/sj.embor.embor741.
26. Ugrinova I, Pashev IG, Pasheva EA. 2009. Post-synthetic acetylation of HMGB1 protein modulates its interactions with supercoiled DNA. Molecular Biology Reports 36:1399-1404 DOI 10.1007/s11033-008-9327-z.
27. Wang FP, Li L, Li J,Wang JY,Wang LY, Jiang W. 2013. High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK. PLoS ONE 8:e64373 DOI 10.1371/journal.pone.0064373.
28. Wang F, Liu S, Du T, Chen H, Li Z, Yan J. 2014. NF-?B inhibition alleviates carbon tetrachloride-induced liver fibrosis via suppression of activated hepatic stellate cells. Experimental and Therapeutic Medicine 8:95-99 DOI 10.3892/etm.2014.1682.
29. West AC, Johnstone RW. 2014. New and emerging HDAC inhibitors for cancer treatment. Journal of Clinical Investigation 124:30-39 DOI 10.1172/JCI69738.
30. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, BlanerWS,Mukherjee P, Friedman SL, Eng FJ. 2005. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54:142-151 DOI 10.1136/gut.2004.042127.
31. Yang H, Antoine DJ, Andersson U, Tracey KJ. 2013. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. Journal of Leukocyte Biology 93:865-873 DOI 10.1189/jlb.1212662.
32. Zhang Y, Ikegami T, Honda A,Miyazaki T, Bouscarel B, Rojkind M, Hyodo I,Matsuzaki Y. 2006. Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats. Hepatology 44:612-622 DOI 10.1002/hep.21315.